Nasdaq:US$14.54 (-0.06) | HKEX:HK$22.45 (-0.20) | AIM:£2.21 (-0.04)
News & Presentations
Previous Article   |   Next Article
Presentations | 12 Oct 2023

Preclinical characterization of HMPL-415, a second-generation SHP2 inhibitor